AR104577A2 - METHODS TO TREAT OR REDUCE THE LIKELIHOOD OF ACQUIRING SYMPTOMS OR DISEASES DUE TO MENOPAUSE - Google Patents

METHODS TO TREAT OR REDUCE THE LIKELIHOOD OF ACQUIRING SYMPTOMS OR DISEASES DUE TO MENOPAUSE

Info

Publication number
AR104577A2
AR104577A2 ARP160101337A ARP160101337A AR104577A2 AR 104577 A2 AR104577 A2 AR 104577A2 AR P160101337 A ARP160101337 A AR P160101337A AR P160101337 A ARP160101337 A AR P160101337A AR 104577 A2 AR104577 A2 AR 104577A2
Authority
AR
Argentina
Prior art keywords
steroid precursor
administered
sex steroid
menopause
diseases due
Prior art date
Application number
ARP160101337A
Other languages
Spanish (es)
Original Assignee
Endorecherche Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endorecherche Inc filed Critical Endorecherche Inc
Publication of AR104577A2 publication Critical patent/AR104577A2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

Reivindicación 1: Un método para tratar y/o reducir la probabilidad de adquirir los síntomas o enfermedades debidos a la menopausia, en mujeres postmenopáusicas, caracterizado porque dicho método comprende administrar un precursor de esteroides sexuales seleccionado del grupo formado por dehidroepiandrosterona, sulfato de dehidroepiandrosterona, androst-5-en-3b,17b-diol y 4-androsten-3,17-diona a un paciente que necesita de dicho tratamiento, en donde dicho precursor de esteroides sexuales es administrada como una cantidad terapéutica que incrementa el nivel de metabolitos de andrógeno en la circulación sin incrementar el nivel en circulación de estradiol por encima de los valores observados en mujeres postmenopáusicas normales con el fin de evitar el riesgo de cáncer de mama y útero. Reivindicación 2: El método de la reivindicación 1, caracterizado porque el precursor de esteroides sexuales es administrado sobre la piel. Reivindicación 3: El método de la reivindicación 1, caracterizado porque el precursor de esteroides sexuales es administrado por vía intravaginal. Reivindicación 4: El método de la reivindicación 1, caracterizado porque el precursor de esteroides sexuales es administrado por vía oral. Reivindicación 24: El método de las reivindicaciones 21 y 22, caracterizado porque el modulador selectivo del receptor de estrógeno presenta la estructura química de fórmula (1).Claim 1: A method for treating and / or reducing the probability of acquiring symptoms or diseases due to menopause, in postmenopausal women, characterized in that said method comprises administering a sexual steroid precursor selected from the group consisting of dehydroepiandrosterone, dehydroepiandrosterone sulfate, androst-5-en-3b, 17b-diol and 4-androsten-3.17-dione a patient in need of such treatment, wherein said sex steroid precursor is administered as a therapeutic amount that increases the metabolite level of androgen in the circulation without increasing the level of estradiol in circulation above the values observed in normal postmenopausal women in order to avoid the risk of breast and uterine cancer. Claim 2: The method of claim 1, characterized in that the sex steroid precursor is administered on the skin. Claim 3: The method of claim 1, characterized in that the sex steroid precursor is administered intravaginally. Claim 4: The method of claim 1, characterized in that the sex steroid precursor is administered orally. Claim 24: The method of claims 21 and 22, characterized in that the selective estrogen receptor modulator has the chemical structure of formula (1).

ARP160101337A 2007-08-10 2016-05-10 METHODS TO TREAT OR REDUCE THE LIKELIHOOD OF ACQUIRING SYMPTOMS OR DISEASES DUE TO MENOPAUSE AR104577A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96427007P 2007-08-10 2007-08-10

Publications (1)

Publication Number Publication Date
AR104577A2 true AR104577A2 (en) 2017-08-02

Family

ID=43618448

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160101337A AR104577A2 (en) 2007-08-10 2016-05-10 METHODS TO TREAT OR REDUCE THE LIKELIHOOD OF ACQUIRING SYMPTOMS OR DISEASES DUE TO MENOPAUSE

Country Status (3)

Country Link
AR (1) AR104577A2 (en)
UA (1) UA100701C2 (en)
ZA (1) ZA201000874B (en)

Also Published As

Publication number Publication date
UA100701C2 (en) 2013-01-25
ZA201000874B (en) 2010-10-27

Similar Documents

Publication Publication Date Title
AR068702A1 (en) PHARMACEUTICAL COMPOSITIONS
Rubinsak et al. Reproductive health care across the lifecourse of the female cancer patient
AR104577A2 (en) METHODS TO TREAT OR REDUCE THE LIKELIHOOD OF ACQUIRING SYMPTOMS OR DISEASES DUE TO MENOPAUSE
Hashmi et al. Complete androgen insensitivity syndrome
US20140155492A1 (en) Composition and method for affecting male and female hormone levels
ES2320662T3 (en) RESTITUTIVE HORMONOTHERAPY AND TREATMENT FOR DEPRESSION WITH DIENOGEST.
JP2015506988A5 (en)
US20150031775A1 (en) Composition and method for affecting male and female hormone levels
US6989163B2 (en) Arrangement to enhance a woman's sexual sensitivity by a combination of phytoestrogens, L-arginine and menthol
Mohamed et al. Breast cancer case using tamoxifen during pregnancy: a case report and literature review
RU2510284C1 (en) Method for integrated treatment of pathozoospermia in males suffering adrenal hyperandrogenism
Appiah et al. Reproductive late effects after hematopoietic stem cell transplant in pediatric, adolescent, and young adult cancer survivors
JP2011518136A5 (en)
Mohakul et al. Role of ormeloxifene (centchroman) in benign mastalgia of diverse origin
Roeca et al. Menopause as a Manifestation of Aging
Srilakshmi et al. Ormeloxifene in DUB
RU2646453C1 (en) Method for atrophic vaginitis treatment
CU20100027A7 (en) PHARMACEUTICAL COMPOSITIONS
Sharma Prophylactic Bilateral Oophorectomy: Does Benefits Outweigh Risks?
Arteni et al. Hormone replacement therapy and autoimmune diseases
Test C NCER
Shree The Role of Steroids and Hormones in Gynecomastia-Factors and Treatments
Sassarini Managing the menopause without estrogen
Zanina et al. Role of estradiol in providing sexual function in men
Grossman et al. Are hormones the answer to low libido?

Legal Events

Date Code Title Description
FB Suspension of granting procedure